The Effectiveness of Mixed Reality as Interventional Tool for the Improvement on Quality of Life for People With Parkinson´s Disease.
NCT06459154
Summary
Parkinson's disease is a chronic, neurodegenerative disease of unknown cause, affecting elderly people over the age of 60. It is the second most common neurodegenerative disease, presenting psychomotor signs and symptoms that lead to impaired functionality and quality of life in affected individuals. Mixed reality involves the delivery of digital stimuli in real time and space through spatial mapping using glasses, safely providing multiple iterations to carry out daily activities. Through this tool and in collaboration with technologically skilled mixed reality developers, the software for the rehabilitation program to be applied to Parkinson's disease patients was also developed. The main objective of this clinical study is to examine the effect of a mixed reality program compared to a traditional physiotherapy program on quality of life and motivation for the participation of people with Parkinson's disease.
Eligibility
For the first interventional phase: Inclusion Criteria: 1\. Male and female over 18 years old 2. Persons with independent gait 3. Normal cognitive ability 5. Greek Native language Exclusion Criteria: 1. Presence of neurological disease 2. Presence of uncontrolled diseases of the circulatory system 3. History of musculoskeletal surgery in the last 6 months 4. Use of a walking aid 5. Partial or total blindness For the second interventional phase: Inclusion Criteria: 1. Male and female over 60 years old 2. Persons with independent gait 3. Normal cognitive ability 5\. Greek Native language Exclusion Criteria: 1. Presence of neurological disease 2. Presence of uncontrolled diseases of the circulatory system 3. History of musculoskeletal surgery in the last 6 months 4. Use of a walking aid 5. Partial or total blindness
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06459154